Why the study?
Does goal-directed therapy improve outcomes in high-risk cardiac patients undergoing off-pump coronary artery bypass?
Does goal-directed therapy improve outcomes in high-risk cardiac patients undergoing off-pump coronary artery bypass?
Goal-directed hemodynamic optimization significantly reduces hospital and ICU length of stay in high-risk patients undergoing off-pump coronary artery bypass.
Answers are grounded in this paper and cite their sources.
May shorten hospital stay in high-risk off-pump CABG; leaves open efficacy in randomized trials.
The length of stay in hospital (LOS-H) (7.42 ± 1.48 vs. 5.61 ± 1.11 days, P < 0.001) and ICU stay (4.2 ± 0.82 vs. 2.53 ± 0.56 days, P < 0.001) were significantly lower in the GDT group as compared to control group. The duration of inotropes (3.24 ± 0.73 vs. 2.89 ± 0.68 h, P = 0.005) was also significantly lower in the GDT group. The two groups did not differ in duration of ventilated hours, mortality, and other complications. The parameters such as ScVO 2 , CI, and EVLW had a strong negative and positive correlation with the LOS-H with r values of - 0.331, -0.319, and 0.798, respectively. The study elucidates the role of a goal-directed hemodynamic optimization for improved outcome in high-risk cardiac patients undergoing OPCAB.
No takes yet. Share an insight, caveat, or question.
Kapoor et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: